The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring the tumor microenvironment (TME) in patients with mismatch repair-deficient (MMRd) endometrial cancer (EC) undergoing immune checkpoint inhibitor (ICI) therapy: Proteomic insights into immune resistance mechanisms.
 
Juan Francisco Grau Béjar
No Relationships to Disclose
 
Qinghe Zeng
No Relationships to Disclose
 
Martin Mehnert
No Relationships to Disclose
 
Emeline Colomba
No Relationships to Disclose
 
Catherine Genestie
No Relationships to Disclose
 
Audrey Le Formal
No Relationships to Disclose
 
Elodie Edmond
No Relationships to Disclose
 
Antoine Amaury Lachaud
No Relationships to Disclose
 
Patricia Pautier
Consulting or Advisory Role - AstraZeneca (Inst); MSD Oncology (Inst); MSD vaccin (Inst); Onxeo (Inst); PharmaMar (Inst); Seagen
Research Funding - Onxeo (Inst); PharmaMar (Inst)
Expert Testimony - GlaxoSmithKline (Inst); Onxeo (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; GlaxoSmithKline; MSD Oncology; OSE Immunotherapeutics; PharmaMar
Other Relationship - PharmaMar
 
Judith Michels
Consulting or Advisory Role - Brenus Pharma; GlaxoSmithKline; Regeneron Pharmaceuticals, Inc.;
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Merck
 
Sebastien Gouy
No Relationships to Disclose
 
Amandine Maulard
No Relationships to Disclose
 
Elisa Yaniz
No Relationships to Disclose
 
Alexandra Leary
Honoraria - Gerson Lehrman Group; Medscape; peervoice
Consulting or Advisory Role - Apmonia Therapeutics (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Seagen (Inst); Tesaro (Inst); zentalis (Inst)
Research Funding - Adaptimmune (Inst); AstraZeneca (Inst); Inivata (Inst); MSD Oncology (Inst); OSE Immunotherapeutics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro